Imuran
Imuran Mechanism of Action Imuran (azathioprine) is a purine analog prodrug that is intracellularly converted to 6‑mercaptopurine (6‑MP). 6‑MP competes with adenosine and guanine nucleotides for incorporation into DNA and…
Impoyz
Impoyz Impoyz (generic: opiy-inazole, marketed as Impoyz) is a once‑daily oral selective Janus kinase (JAK)1/2 inhibitor used primarily in the management of moderate to severe rheumatoid arthritis (RA) refractory to…
Imitrex
Imitrex (Sumatriptan) Mechanism of Action Selective 5‑HT₁B/1D receptor agonist – activates serotonin receptors on cranial arterial smooth muscle. Induces cerebral vasoconstriction – counteracts the vasodilation believed to drive migraine pain.…
Imiquimod
Imiquimod Imiquimod (trade names: Aldara®, Imferon®) is a topical immune‑stimulating agent that acts as a Toll‑Like Receptor 7 (TLR7) agonist, inducing innate and adaptive antiviral and antitumor responses. Mechanism of…
Imipramine
Imipramine Imipramine is a tricyclic antidepressant (TCA) commonly used for depressive disorders and certain neuropathic pains. It has a unique pharmacological profile that makes it useful in both psychiatric and…
Imfinzi
Imfinzi Imfinzi (durvalumab) is a human monoclonal IgG1 antibody that selectively blocks the interaction of programmed death‑ligand 1 (PD‑L1) with its receptors PD‑1 and B7‑1, thereby restoring antitumor T‑cell responses.…
Imdur
Imdur Mechanism of Action Imdur is the brand name for isosorbide mononitrate (IMN), a nitrate vasodilator. Release & Metabolism: Oral IMN is rapidly hydrolyzed to isosorbide dinitrate and subsequently to…
Imdelltra
Imdelltra > Disclaimer: > There is currently no publicly available, peer‑reviewed pharmacological data on a drug named Imdelltra in the major drug references, FDA drug database, or peer‑reviewed literature. Consequently,…
Imbruvica
Imbruvica Imbruvica (ibrutinib mesylate) is an oral Bruton's tyrosine kinase (BTK) inhibitor approved for several B‑cell malignancies. It targets malignant B‑cells by disrupting B‑cell receptor (BCR) signaling, leading to apoptosis…
Imatinib
Imatinib Mechanism of Action Imatinib is a tyrosine kinase inhibitor (TKI) that competitively binds the ATP‑binding pocket of several oncogenic kinases: BCR‑ABL (the fusion protein in chronic myeloid leukemia). c‑KIT…